Symcel Nabs SEK5.6m To Take Calorimetry Tech Into Medical Dx
This article was originally published in Clinica
Executive Summary
Swedish firm Symcel has set its sights on the medical diagnostics field, in particular the area of antibiotic drug resistance, as part of a strategy to expand its calScreener calorimetric technology for cell-based assay beyond the current drug discovery and academic research applications.